Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Pharmacodynamic effects of orally administered dexlipotam on endothelial function in type 2-diabetic patients
BPC-157 : TB500 (Thymosin Beta 4) : BPC-157 & TB500 (Thymosin Beta 4) CERTIFICATES OF ANALYSIS 6 COAs BN-25BT55-004 Current Variant: Size: 5mg-5mg BPC-157 TB-500 (TB4) 5.89 mg / 5.73 mg / 5.68 mg / 5.57 mg BN-25BT11-002 Current Variant: Size: 10mg-10mg BPC-157 10.86 mg / 10.89 mg TB-500 10.71 mg / 10.73 mg BN-26BT11-001 Upcoming Variant: Size: 10mg-10mg BPC-157 11.7 mg / 11.85 mg TB-500 11.54 mg / 11.44 mg BN-24BT55 Upcoming Variant: Size: 5mg-5mg BPC-157 5.57 mg TB-500 5.49 mg BN-25BT11-001 Previous Variant: Size: 10mg-10mg BN-24BT55-001 Previous Variant: 5 mg / 5 mg Formulation BPC-157 and TB-500 (Thymosin Beta-4) are research peptides supplied for use in controlled laboratory and analytical environments
When ready, call (919) 797-0996 to schedule your consultation
Storage and Administration Both compounds are administered as subcutaneous injections, typically in the abdomen, thigh, or upper arm
